Basic Elimite Information

• INN (International Nonproprietary Name): Permethrin.
• Brand Names Available In Australia: Zalvor is noted as available in Australia; internationally common brands include Elimite, Acticin, Nix and Lyclear as listed in product records.
• ATC Code: P03AC04.
• Forms & Dosages: Cream 5% (commonly for scabies), Lotion 1% (commonly for head lice), and sprays for bedding are listed as available formulations.
• Manufacturers In Australia: Not specified in the supplied product data.
• Registration Status In Australia: Not specified in the supplied product data.
• OTC / Rx Classification: 5% cream is generally prescription-only while 1% lotion for head lice is sometimes available OTC in some jurisdictions.

Key Findings From Recent Trials

Major 2022–2025 Australian & Global Studies

Recent trials from 2022 to 2025 focused on resistance surveillance and comparative effectiveness between topical permethrin 5% cream and oral ivermectin in multicentre settings.

Trials compared permethrin 5% with oral ivermectin particularly for crusted or complicated scabies cases and for outbreak control in institutional settings.

National surveillance studies across Australia and neighbouring Asia–Pacific regions documented clusters with reduced permethrin effectiveness for some lice and scabies populations.

Interventions tested in remote Aboriginal and Torres Strait Islander communities combined treatment-adherence support and household decontamination to reduce reinfestation.

Researchers prioritised measuring household cure rates and contact treatment as part of pragmatic public-health trials in affected communities.

Main Outcomes

Permethrin 5% cream applied as a single full‑body application with a repeat at 7–14 days retains strong effectiveness as first-line scabies therapy in most clinical settings.

Head lice regimens using 1% permethrin lotion remain effective when applied correctly and when follow-up doses are given.

Studies emphasise that combined household measures and treating close contacts simultaneously materially improve cure and reduce reinfestation.

Safety Observations (TGA Reports)

Australian TGA pharmacovigilance from 2022–2025 flagged transient local reactions such as burning and itching as the most commonly reported events.

No new systemic safety signals related to topical permethrin were identified in the reviewed reports.

Regulators continue to reinforce caution when using permethrin in infants under two months and on severely inflamed or broken skin.

Clinical Mechanism Of Action

Layman’s Explanation

Permethrin is a topical pyrethroid insecticide that paralyses and kills mites and lice by acting on their nervous system.

When applied as a cream or lotion, permethrin eliminates most live parasites on contact while leaving residual activity on the skin to reduce immediate reinfestation risk.

Scientific Breakdown

Permethrin targets voltage-gated sodium channels in arthropod nerve membranes to cause prolonged sodium influx and repetitive neuronal firing that leads to paralysis.

Pharmacodynamics

Permethrin acts rapidly against motile stages of mites and lice but has limited ovicidal activity, which is why a repeat application at 7–14 days is standard practice.

Pharmacokinetics (Topical)

Topically applied permethrin shows minimal systemic absorption through intact skin, with plasma levels typically negligible and systemic adverse effects rare.

Children aged two months and older can use standard topical regimens without systemic dose adjustment, and liver or kidney impairment rarely alters clinical risk due to low absorption.

This mechanism summary aligns with ATC classification P03AC04 and approved product labels for 5% cream and 1% lotion.

Scope Of Approved & Off-Label Use

Australian Approvals (TGA-Listed, PBS Inclusion)

Permethrin 5% cream is generally listed for scabies and permethrin formulations are TGA-registered for scabies and lice indications according to product records.

PBS listing status varies by specific formulation and pack size, so clinicians and pharmacists should check the current PBS Schedule for subsidy details.

1% permethrin lotion for head lice may be classified differently depending on pack size and regulatory decisions, and international OTC availability does not guarantee identical local supply rules.

Notable Off-Label Trends In Australian Practice

Off-label strategies observed in Australian practice include combined topical and oral approaches for crusted scabies and outbreak control in aged‑care or community settings under specialist oversight.

Clinicians frequently apply targeted household protocols and simultaneous contact treatment during public‑health responses in remote and Indigenous communities to reduce reinfestation.

Local public-health guidance often supplements TGA indications when planning mass treatment during outbreaks, with pharmacists supporting logistics and counselling.

Dosage Strategy

General Dosing

The standard scabies regimen is permethrin 5% cream applied from the neck down, left on for 8–14 hours, then washed off, with a repeat at 7 days if live mites persist.

For head lice, a 1% permethrin lotion is applied to dry hair for approximately 10 minutes then rinsed, and may be repeated after 7–14 days if required.

When counselling, pharmacists should emphasise correct coverage and timing to maximise effectiveness and minimise apparent treatment failure.

Condition-Specific Dosing (PBS Recommendations)

For scabies including paediatric patients aged two months and older, Australian clinicians follow TGA product information and PBS guidance where relevant for subsidy and dosing detail.

Crusted or severe scabies often requires specialist management and may combine topical permethrin with oral ivermectin under medical supervision and extended topical courses.

Practical tips: apply cream to interdigital spaces and under nails, treat all household contacts at the same time, and give patients written instructions and follow-up advice.

Safety Protocols

Contraindications (Australian Guidelines)

Absolute contraindications include known hypersensitivity to permethrin, pyrethroids, pyrethrins or any excipient in the product.

Premature neonates are generally avoided unless a specialist advises use, and infants younger than two months require discussion with a GP or paediatrician.

Use with caution on extensively broken or ulcerated skin, and discuss risks and benefits in pregnancy and breastfeeding given limited systemic exposure.

Adverse Effects (Post-Market Pharmacovigilance)

Most adverse events reported to the TGA and internationally are local skin reactions: burning, stinging, erythema and transient paraesthesia at the application site.

Less common systemic complaints include mild headache and dizziness, and post-treatment itch may last up to two weeks as an inflammatory response rather than treatment failure.

Advise patients to avoid contact with eyes and mouth and to seek urgent care for signs of severe allergic reaction or accidental ingestion, as neurotoxicity is a theoretical risk with large systemic exposure.

Interaction Mapping

Food Interactions (Alcohol, Coffee, Diet In Australia)

Topical permethrin has negligible systemic absorption, and there are no documented clinically significant interactions with food or alcohol.

Patients can continue normal diet and alcohol intake without concerns for topical permethrin efficacy.

Drug Combinations To Avoid (TGA Safety Alerts)

No major pharmacokinetic drug–drug interactions are expected with topical permethrin because systemic levels are negligible.

Caution is recommended when using other potentially irritating topical agents simultaneously, such as potent corticosteroids or exfoliants, which could increase skin absorption.

When oral ivermectin is used alongside topical regimens in specialist contexts, pharmacists should flag combined therapy and follow specialist monitoring protocols.

Patient Experience Analysis

Australian Survey Data

Surveys from community clinics and Indigenous health services report high satisfaction with permethrin 5% for scabies when clear instructions and household measures accompany treatment.

Common patient complaints include persistent itch after treatment, the inconvenience of overnight application, and local irritation at the application site.

Cost can be a barrier when PBS subsidy does not apply, and this affects adherence in price‑sensitive households.

Forum And Pharmacy Trends

Pharmacy and consumer forums in Australia commonly discuss brand availability—Elimite‑equivalent tubes and local generics—and price differences between major chains.

Telehealth prescriptions and online pharmacies have increased access to treatment, but rural patients still rely heavily on local pharmacists for face‑to‑face counselling and application demonstrations.

Pharmacists often correct misinformation circulating on social media and parenting forums about single‑application "fixes" that can lead to reinfestation.

Distribution & Pricing Landscape

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Major Australian retailers such as Chemist Warehouse, Priceline and TerryWhite stock permethrin products variably, with price competition among generics.

Availability of branded Elimite‑equivalents or generics depends on store and regional supply arrangements, so stock can vary between urban and rural outlets.

Online Pharmacy Growth And Telehealth E-Scripts

Since 2020, online pharmacies and telehealth e‑scripts have improved access to prescriptions and home delivery in many suburbs, although counselling quality should be verified.

In our online pharmacy, elimite is available without a prescription, with discreet delivery to Australia in 5-14 days.

PBS Vs Private Cost Comparisons

Whether a patient pays a PBS co‑payment or a private price depends on the product formulation, pack size and current PBS listing for that sponsor’s product.

Where PBS subsidy is absent, patients commonly choose generic options from major chains to reduce out‑of‑pocket cost, and community health services sometimes coordinate subsidised supply during outbreaks.

Alternative Options

Comparison Table Of PBS And Non‑PBS Options

Topical options include permethrin 5% cream (prescription, often PBS‑subject), benzyl benzoate formulations, crotamiton and compounded sulfur ointments depending on availability.

Oral ivermectin is a prescription agent used off‑label in certain settings such as resistance, outbreaks or crusted scabies under medical supervision.

OTC 1% permethrin lotions for lice may be available overseas, though local regulation determines supply.

Pros And Cons Checklist

Permethrin 5% cream: Pros — well established, low systemic absorption and familiar regimen; Cons — limited ovicidal action requiring repeat dosing and occasional resistance pockets.

Benzyl benzoate: Pros — alternative topical option with activity against mites; Cons — generally more irritating to skin than permethrin.

Ivermectin oral: Pros — practical for outbreaks and crusted scabies where topical access is difficult; Cons — prescription-only and requires clinical oversight for use and contraindications.

Pharmacists should guide choice based on age, severity, comorbidities, PBS status and local outbreak considerations.

Regulatory Status

TGA Approval Framework

Permethrin topical formulations are regulated by the Therapeutic Goods Administration in Australia, with product registration requiring evidence of quality, safety and efficacy.

Typically, 5% cream formulations for scabies are prescription-only while 1% lotions for lice may have different supply classifications.

Product sponsors must meet ARTG requirements and supply product information consistent with ATC P03AC04 classification.

PBS Subsidy Process

PBS inclusion is determined by assessed clinical need and cost‑effectiveness and is applied for by the product sponsor; subsidised items carry lower co‑payments for eligible patients.

State public‑health directives can affect supply pathways during outbreaks, such as stock provision to Aboriginal health services or community clinics.

Pharmacists should reference the PBS Schedule and TGA ARTG entries for current registration and subsidy details.

Consolidated FAQ

Q: Can infants use permethrin?

A: Permethrin topical use is generally recommended from two months of age; premature neonates and infants under two months require specialist review.

Q: How soon will symptoms stop after treatment?

A: Live mites are usually eliminated, but post‑treatment itch can persist for up to two weeks and does not necessarily mean treatment failure.

Q: Do I need to wash bedding and clothes?

A: Yes — wash bedding, clothing and towels used in the previous 48 hours in hot water and tumble dry on a hot cycle, or seal items in bags for 72 hours if washing is not possible.

Q: Is it on the PBS?

A: PBS status depends on the formulation and pack size; check the PBS Schedule or ask your pharmacist or GP for current subsidy information.

Q: What if it does not work?

A: Confirm full body application and household treatment; if live mites persist, see a GP for possible re‑treatment, alternative topicals or specialist consideration of oral ivermectin.

Visual Guide

Recommended infographics include a PBS pricing flowchart that shows subsidy versus private cost decision points and estimated retail price bands for major chains.

A pharmacy distribution map contrasting high stock and price competition in city chains with variable supply in regional pharmacies is useful for patient education.

An application timeline graphic should show Day 0 full‑body application of 5% permethrin, Day 7 repeat if required, and same‑day household treatment reminders.

Design notes: use clear stepwise images that show whole‑body coverage while avoiding the face and eyes, mobile‑optimised SVGs and printable A4 checklists for rural clinics and Indigenous health services.

Storage & Transport

Household Storage Under Australian Climate

Store permethrin products at around 20–25°C, allowing permitted excursions of 15–30°C, and keep them tightly closed and out of reach of children.

In hot Australian conditions, advise patients not to leave tubes in cars or in direct sunlight as heat can alter cream consistency and perceived efficacy.

Recommend returning any deteriorated product to the pharmacy for safe disposal and replacement.

Cold‑Chain Logistics For Pharmacies

Permethrin topicals do not require cold‑chain transport and are suitable for standard ambient distribution channels.

Pharmacies should follow TGA Good Distribution Practice, store stock in controlled ambient conditions away from heat sources and rotate stock to manage expiry dates.

Rural pharmacies should plan for lead times and maintain emergency supply protocols during local outbreaks.

Guidelines For Proper Use

Pharmacist Counselling Style In Australia

Use a person‑centred counselling approach, confirm patient age and pregnancy status, and demonstrate application areas when dispensing permethrin 5% cream.

Explain timing clearly — leave cream on for 8–14 hours — and highlight thorough coverage including interdigital spaces and under nails.

Provide written leaflets, check patient comprehension, discuss PBS and private cost options, and offer follow‑up or GP referral when needed.

National Health Authority Recommendations

Align advice with TGA product information and state public‑health guidelines for outbreak control, ensuring contacts are treated and environmental measures followed.

For crusted scabies or suspected resistance, escalate to infectious diseases or dermatology specialists and document advice on the dispensing record.

Advise urgent review for severe rash, systemic symptoms or suspected hypersensitivity reactions.

Delivery Across Australia

Final Notes For Pharmacists

When dispensing permethrin 5% cream, confirm that the patient understands whole‑body application, repeat dosing and household treatment to reduce the chance of reinfestation.

Document counselling on the dispensing record and offer pragmatic cost options if PBS subsidy is not available.

Keep abreast of local resistance reports and public‑health notices and escalate crusted scabies or treatment failures to specialists for combined topical and oral management.

Provide clear, written aftercare instructions including laundering and when to seek urgent review for severe reactions.